Brain PET-MRI Systems Market by Phases (Pre-clinical and Clinical), Products (Helium-free PET-MRI Systems and Traditional PET-MRI Systems), End-users (Diagnostic Imaging Centers, Hospitals, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021-2028
The global brain PET-MRI systems market size was valued at 294.5 million in 2020 and is anticipated to expand at a substantial CAGR during the forecast period, 2021-2028. The growth of the market is attributed to the increasing incidence of neurological disorders.
Positron emission tomography (PET) provides 3-dimensional and high-resolution imaging of molecular, physiologic, and functional targets. Brain PET-MRI is a two in one test primarily designed to bring out highly detailed pictures of the brain. Although positron emission tomography (PET) captures the image of the whole brain, it has insufficient attenuation, lacks spatial resolution, needs scatter correction, and have low sensitivity. As a result of this, a combined technique with magnetic resonance imaging (MRI) helps overcome the underlying problems. The diagnosis of neurological disorders has improved due to the integration of MRI with PET. The brain’s biochemical and psychological processes of brain can be observed concurrently due to the introduction of new opportunities by brain PET-MRI systems. There are various challenges faced by the brain PET-MRI systems that include appropriate construction of PET-MRI system, placement of PET system and photomultiplier tubes (PMTs) in the high magnetic field, and development of attenuation maps for PET images.
The increase in the spread of COVID-19 pandemic during the peak time of the outbreak has resulted in to rise in demand for new treatments and diagnosis. Several researches show that the pandemic is expected to have an effect on individual’s brain and can be measured accurately with the use of brain PET-MRI. As the number of the cases for psychological impact on the COVID patients are rising, the demand for brain PET-MRI scans is in surge rapidly as it helps to examine and analyze some cognitive impairment and loss in neurological function right away. However, some of the patients started facing such impact only in six months after the diagnosis.
Market Trends, Drivers, Restraints, and Opportunities
- Growing demand for brain PET-MRI systems in pharmaceuticals is anticipated to fuel the market growth during the forecast period.
- Increasing integration of PET with several other radio isotopes in radiopharmaceuticals is expected to boost the market growth.
- Strict, rigid, and rigorous guidelines imposed by governments are projected to restrain the market expansion during the forecast period.
- Installation of brain PET-MRI systems is costly and a challenging task that can act as a major restraining factor of the market growth in the coming years.
- Advancement in diagnostics applications coupled with technological advancements in PET-MRI systems are projected to create lucrative opportunities for market growth.
Scope of the Report
The report on the global brain PET-MRI systems market includes an assessment of the market, trends, and segments. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Brain PET-MRI Systems Market – Global Industry Analysis, Growth, Share, Size, Trends, And Forecast |
Base Year |
2020 |
Historic Data |
2018–2019 |
Forecast Period |
2021–2028 |
Segmentation |
Phases (Pre-clinical and Clinical), Products (Helium-free PET-MRI Systems and Traditional PET-MRI Systems), and End-users (Diagnostic Imaging Centers, Hospitals, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Koninklijke Philips N.V.; Bruker; GE Healthcare; Mediso Ltd.; Cubresa Inc.; MR Solutions; Aspect Imaging; and Siemens Healthineers AG |
Market Segment Insights
Clinical segment is anticipated to expand at a fast pace
On the basis of phases, the global brain PET-MRI systems market is bifurcated into pre-clinical and clinical. The pre-clinical segment held a large share of the market in 2019 and is expected to account for a key market share during the projected period. The segment growth is attributed to the huge number of pre-clinical studies performed on the brain PET-MRI systems in order to understand the efficiency of diagnosis of neurological disorders. However, the clinical segment is anticipated to expand at a fast pace in the coming years owing to the growing number of clinical trials for neurological disorders. At present, more than 250 clinical trials are being conducted for neurological disorders. Effective results are also achieved in the pre-clinical trials that enable the brain PET-MRI systems to enter the clinical trials and drive the segment growth.
Helium-free PET-MRI systems segment is estimated to grow at a high rate
Based on products, the market is divided into helium-free PET-MRI systems and traditional PET-MRI systems. The traditional PET-MRI systems is projected to constitute a robust share of the market in terms of revenue during the forecast period owing to the development of such devices by the key players. On the other hand, the helium-free PET-MRI Systems is estimated to grow at a high rate in the coming years. There are some complications associated with the traditional systems and using the helium-free PET-MRI Systems can overcome the challenges. This is anticipated to boost the market segment growth.
Diagnostic imaging centers segment is expected to grow at a rapid pace
On the basis of end-users, the global brain PET-MRI systems market is divided into diagnostic imaging centers, hospitals, and others. The hospitals segment constituted a major share of the market in terms of revenue in 2019 and is anticipated to exhibit a robust CAGR during the forecast period due to rising cases of neurological disorders across the globe. Every year, approximately 500,000 cases of amyotrophic lateral sclerosis, multiple sclerosis, and brain tumor are diagnosed and majority of the cases are registered in hospitals that are largely equipped with several advanced systems.
The diagnostic imaging centers segment, however, is expected to grow at a rapid pace during the projected period owing to the preference of diagnostic imaging centers by patients in order to avoid the high cost of procedures and lengthy-time waits associated with the hospitals. Moreover, diagnostic imaging centers provide an enhanced diagnosis by using hybrid imaging devices. On the other hand, the others segment is estimated to grow at a significant CAGR during the forecast period due to the wide installation of these devices by universities and research centers for research purposes in order to understand the effectiveness of these devices in the diagnosis of neurological disorders.
Asia Pacific is anticipated to register a robust CAGR
In terms of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia Pacific is anticipated to register a robust CAGR during the forecast period attributed to the rising adoption of diagnostic machines that are advanced by the universities and research centers in the region. On the other hand, North America held a significant share of the market in 2019 and is projected to constitute a major market share in the coming years owing to the increasing incidence of neurological disorders in the region. Meanwhile, the market in Europe is expected to hold a considerable revenue share during the projected period owing to increasing awareness towards hybrid imaging. Educational and training programs are conducted by non-profit organizations for physicists, technologists, and scientists to educate and train people on advanced technologies of hybrid imaging.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Brain PETMRI Systems Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Brain PETMRI Systems Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Brain PETMRI Systems Market - Supply Chain
4.5. Global Brain PETMRI Systems Market Forecast
4.5.1. Brain PETMRI Systems Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Brain PETMRI Systems Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Brain PETMRI Systems Market Absolute $ Opportunity
5. Global Brain PETMRI Systems Market Analysis and Forecast by End Users
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by End Users
5.2.2. Y-o-Y Growth Projections by End Users
5.3. Brain PETMRI Systems Market Size and Volume Forecast by End Users
5.3.1. Diagnostic Imaging Centers
5.3.2. Hospitals
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by End Users
5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Brain PETMRI Systems Market Analysis and Forecast by Region
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Region
6.2.2. Y-o-Y Growth Projections by Region
6.3. Brain PETMRI Systems Market Size and Volume Forecast by Region
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa (MEA)
6.4. Absolute $ Opportunity Assessment by Region
6.5. Market Attractiveness/Growth Potential Analysis by Region
6.6. Global Brain PETMRI Systems Demand Share Forecast, 2019-2026
7. North America Brain PETMRI Systems Market Analysis and Forecast
7.1. Introduction
7.1.1. Basis Point Share (BPS) Analysis by Country
7.1.2. Y-o-Y Growth Projections by Country
7.2. North America Brain PETMRI Systems Market Size and Volume Forecast by Country
7.2.1. U.S.
7.2.2. Canada
7.3. Absolute $ Opportunity Assessment by Country
7.4. North America Brain PETMRI Systems Market Size and Volume Forecast by End Users
7.4.1. Diagnostic Imaging Centers
7.4.2. Hospitals
7.4.3. Others
7.5. Basis Point Share (BPS) Analysis by End Users
7.6. Y-o-Y Growth Projections by End Users
7.7. Market Attractiveness/Growth Potential Analysis
7.7.1. By Country
7.7.2. By Product Type
7.7.3. By Application
7.8. North America Brain PETMRI Systems Demand Share Forecast, 2019-2026
8. Latin America Brain PETMRI Systems Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.1.3. Latin America Average Pricing Analysis
8.2. Latin America Brain PETMRI Systems Market Size and Volume Forecast by Country
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Absolute $ Opportunity Assessment by Country
8.4. Latin America Brain PETMRI Systems Market Size and Volume Forecast by End Users
8.4.1. Diagnostic Imaging Centers
8.4.2. Hospitals
8.4.3. Others
8.5. Basis Point Share (BPS) Analysis by End Users
8.6. Y-o-Y Growth Projections by End Users
8.7. Market Attractiveness/Growth Potential Analysis
8.7.1. By Country
8.7.2. By Product Type
8.7.3. By Application
8.8. Latin America Brain PETMRI Systems Demand Share Forecast, 2019-2026
9. Europe Brain PETMRI Systems Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Europe Average Pricing Analysis
9.2. Europe Brain PETMRI Systems Market Size and Volume Forecast by Country
9.2.1. Germany
9.2.2. France
9.2.3. Italy
9.2.4. U.K.
9.2.5. Spain
9.2.6. Russia
9.2.7. Rest of Europe
9.3. Absolute $ Opportunity Assessment by Country
9.4. Europe Brain PETMRI Systems Market Size and Volume Forecast by End Users
9.4.1. Diagnostic Imaging Centers
9.4.2. Hospitals
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by End Users
9.6. Y-o-Y Growth Projections by End Users
9.7. Market Attractiveness/Growth Potential Analysis
9.7.1. By Country
9.7.2. By Product Type
9.7.3. By Application
9.8. Europe Brain PETMRI Systems Demand Share Forecast, 2019-2026
10. Asia Pacific Brain PETMRI Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Asia Pacific Average Pricing Analysis
10.2. Asia Pacific Brain PETMRI Systems Market Size and Volume Forecast by Country
10.2.1. China
10.2.2. Japan
10.2.3. South Korea
10.2.4. India
10.2.5. Australia
10.2.6. Rest of Asia Pacific (APAC)
10.3. Absolute $ Opportunity Assessment by Country
10.4. Asia Pacific Brain PETMRI Systems Market Size and Volume Forecast by End Users
10.4.1. Diagnostic Imaging Centers
10.4.2. Hospitals
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by End Users
10.6. Y-o-Y Growth Projections by End Users
10.7. Market Attractiveness/Growth Potential Analysis
10.7.1. By Country
10.7.2. By Product Type
10.7.3. By Application
10.8. Asia Pacific Brain PETMRI Systems Demand Share Forecast, 2019-2026
11. Middle East & Africa Brain PETMRI Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Middle East & Africa Average Pricing Analysis
11.2. Middle East & Africa Brain PETMRI Systems Market Size and Volume Forecast by Country
11.2.1. Saudi Arabia
11.2.2. South Africa
11.2.3. UAE
11.2.4. Rest of Middle East & Africa (MEA)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Middle East & Africa Brain PETMRI Systems Market Size and Volume Forecast by End Users
11.4.1. Diagnostic Imaging Centers
11.4.2. Hospitals
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by End Users
11.6. Y-o-Y Growth Projections by End Users
11.7. Market Attractiveness/Growth Potential Analysis
11.7.1. By Country
11.7.2. By Product Type
11.7.3. By Application
11.8. Middle East & Africa Brain PETMRI Systems Demand Share Forecast, 2019-2026
12. Competition Landscape
12.1. Global Brain PETMRI Systems Market: Market Share Analysis
12.2. Brain PETMRI Systems Distributors and Customers
12.3. Brain PETMRI Systems Market: Competitive Dashboard
12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
12.4.1. Koninklijke Philips N.V.
12.4.2. Bruker
12.4.3. GE Healthcare
12.4.4. Mediso Ltd.
12.4.5. Cubresa Inc.
12.4.6. MR Solutions
12.4.7. Aspect Imaging
12.4.8. Siemens Healthineers AG